Pharma Workforce Denmark ApS

APSActiveAdvertising protection

CVR 45480704Strøby Bygade 16, 4671 StrøbyTemporary employment agency activities and other human resource provisions· NACE 7820Est. 2025 · 1 year old— employeeshttps://phawo.dk

Overview

Pharma Workforce Denmark ApS is a Danish APS based in Strøby, operating in the Temporary employment agency activities and other human resource provisions sector. Incorporated in 2025, the company reported a gross profit of DKK 481.7k in its latest annual filing.

Gross profit 2026

481.7K DKK

−6246% vs 2025

EBITDA margin (of gross profit)

100.0 %

+6246% vs 2025

Net profit 2026

373.8K DKK

+4870% vs 2025

Key ratios

See full ratios →

59.2 %

Strong

Among the 40% highest rated companies in the industry

20252026

2.4×

Strong

Among the 40% highest rated companies in the industry

20252026

57.3 %

Very strong

Among the 10% highest rated companies in the industry

20252026

EBITDA — year on year

DKK thousands

Key figures

Annual report 2026

Gross profit	481.7K DKK	-6246%
EBITDA	481.7K DKK	+6246%
Net profit	373.8K DKK	+4870%
Total assets	652.4K DKK	+4465%
Equity	386K DKK	+3073%
Employees	—	—

Contact

Address

Strøby Bygade 16, 4671 Strøby

Phone

+45 5355 5945

lvi@phawo.dk

Website

https://phawo.dk

Advertising protection

Active — opted out of marketing use

Risika for professionals

Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.

Visit risika.com

Financial development

In its most recent annual report (2026), Pharma Workforce Denmark ApS reported a gross profit of DKK 481.7k. The figures on this page draw on 2 annual filings covering 2025 to 2026. The bottom line showed a net profit of DKK 373.8k, and the EBITDA margin stood at 100%.

At the end of 2026, equity financed 59.2% of the balance sheet, and current assets covered short-term debt 2.4 times.

Financials

Gross profit

DKK thousands

EBITDA

DKK thousands

Income statement

DKK thousands

Item	2026	2025
Gross profit	482	-8
Staff expenses	-0	-0
EBITDA	482	-8
Depreciation & amort.	-0	-0
EBIT	482	-8
Net financials	-4	0
Profit before tax	478	-8
Tax	104	-0
Net profit	374	-8

Get a credit rating – not just the numbers

Financial statements show the past. Risika gives you a score and a recommended credit limit, so you know what the numbers mean for your risk.

See the credit rating

Balance sheet

DKK thousands

Item	2026	2025
Total assets	652	14
Equity	386	12
Long-term debt	0	0
Short-term debt	266	2
Total debt	266	2

Financial ratios

5-year trend

EBITDA margin (of gross profit)

100.0 %

20252026

Equity ratio

59.2 %

Strong

Among the 40% highest rated companies in the industry

20252026

Return on equity

96.8 %

Very strong

Among the 10% highest rated companies in the industry

20252026

Net profit margin (of gross profit)

77.6 %

20252026

Asset turnover (of gross profit)

0.74×

20252026

Debt / equity

0.69×

Average

Around the average of companies in the same industry

20252026

Sector performance

22 of 28 ratios graded

28 financial ratios from the latest filing, each graded against companies in the same industry.

Profitability

Return on equity (ROE)Very strong

Among the 10% highest rated companies in the industry

Net profit as a percentage of equity — the return the owners earned on their invested capital this year.

Return on assets (ROA)Very strong

Among the 10% highest rated companies in the industry

Net profit as a percentage of total assets — the return generated on the capital employed.

Return on net assets (RONA)Very strong

Among the 10% highest rated companies in the industry

Profit relative to net assets (total assets minus total debt) — the ability to generate earnings from the net asset base alone.

Basic earning power (BEP)Very strong

Among the 10% highest rated companies in the industry

EBIT relative to total assets — the company's earning power before the effects of tax and financial leverage.

Gross marginNot rated

Cannot be graded — the figures this ratio builds on are not available in the latest filing.

The gross result as a share of revenue — how much of the revenue is left after variable costs to cover the company's fixed costs.

Operating marginNot rated

Cannot be graded — the figures this ratio builds on are not available in the latest filing.

EBIT as a share of revenue — the share of revenue remaining as earnings once all operating costs are covered. A key measure of earning power.

Net profit marginNot rated

Cannot be graded — the figures this ratio builds on are not available in the latest filing.

The profit for the year as a share of revenue — the company's ability to turn revenue into profit.

Capacity ratioNot rated

Cannot be graded — the figures this ratio builds on are not available in the latest filing.

Shows how strongly fixed costs weigh on the gross result — a high ratio means fixed costs take only a small bite out of the earnings from basic operations.

Liquidity

Current ratioStrong

Among the 40% highest rated companies in the industry

Current assets relative to short-term debt — the ability to settle short-term obligations with current assets alone. Around 150% is considered satisfactory from a credit perspective.

Quick ratioStrong

Among the 40% highest rated companies in the industry

Current assets excluding inventory relative to short-term debt — whether the most liquid assets alone can cover the short-term obligations. A value of 1 or above signals a healthy liquidity position.

Cash ratioAverage

Around the average of companies in the same industry

Cash relative to short-term debt — the ability to repay short-term obligations with cash alone.

Current assets to equityWeak

Among the 40% lowest rated companies in the industry

Current assets relative to equity — an indicator of the balance-sheet structure and of the company's short- and long-term financing. The healthy level is highly industry-dependent.

Fixed assets to long-term capitalStrong

Among the 40% highest rated companies in the industry

Fixed assets relative to long-term capital (equity plus long-term liabilities). Below 100% means the long-term capital finances more than just the fixed assets — a healthier liquidity position.

Cash conversion ratioAverage

Around the average of companies in the same industry

Cash flow relative to profit — the ability to convert reported profits into accessible cash.

Debt & solvency

Solidity ratioStrong

Among the 40% highest rated companies in the industry

Equity as a share of total assets — the ability to absorb losses. Around 40% is considered satisfactory from a credit perspective.

Debt ratioStrong

Among the 40% highest rated companies in the industry

Total debt relative to the balance-sheet total — the share of the assets financed by debt rather than equity.

Debt to equityAverage

Around the average of companies in the same industry

Debt relative to equity — the company's leverage. A higher value means heavier reliance on debt financing.

Liabilities to equityAverage

Around the average of companies in the same industry

Total liabilities relative to equity — whether the company operates primarily on borrowed capital or on its own.

Income to debtVery strong

Among the 10% highest rated companies in the industry

Profit relative to debt — the ability to create earnings while operating with debt.

EBITDA to debtVery strong

Among the 10% highest rated companies in the industry

EBITDA relative to debt — how much operating earnings are available to service the debt.

Interest coverageVery strong

Among the 20% highest rated companies in the industry

The ability to pay the interest on the company's debt out of its earnings.

Interest rate on debtWeak

Among the 40% lowest rated companies in the industry

Financial expenses relative to total liabilities — the effective interest rate the company pays on its debt.

Interest marginVery strong

Among the 10% highest rated companies in the industry

The return on assets minus the interest rate on debt. Positive means the company benefits from operating with debt; negative means the debt makes it worse off.

Efficiency & development

Equity to contributed capitalStrong

Among the 30% highest rated companies in the industry

Total equity relative to the capital the owners contributed — how the equity has developed from its starting point.

One-year change in equityVery strong

Among the 10% highest rated companies in the industry

The size of this year's increase or decrease in the company's equity.

One-year change in debtVery weak

Among the 10% lowest rated companies in the industry

The size of this year's increase or decrease in the company's debt.

Asset turnoverNot rated

Cannot be graded — the figures this ratio builds on are not available in the latest filing.

Revenue relative to total assets — the ability to generate revenue from the asset base.

Inventory turnoverNot rated

Cannot be graded — the figures this ratio builds on are not available in the latest filing.

Revenue relative to inventory — how many times a year the inventory is sold and replaced. A low value can indicate weak sales or excess inventory.

Annual reports & filings

Annual report 2026
Filed via CVR / Virk · Period 2025-07-01 – 2026-06-30
View PDF
Annual report 2025
Filed via CVR / Virk · Period 2025-03-14 – 2025-06-30
View PDF

People & ownership

Management

Actively employed in the business

Name	Role	Member since
Current (1)
LV Lasse Vindahl Chief Executive Officer	Chief Executive Officer	2026

Former (1)


SS Steffen Stenbøg Jensen Management	Management	2025 – 2026

Board of directors

Non-executive oversight

No data on file.

Shareholders

Active legal owners

Shareholder	Type	Ownership	Votes	Registered
SL Holding 2017 ApS	Company	50–66.65%	50–66.65%	2025
Vindahl Holding ApS	Company	50–66.65%	50–66.65%	2025

Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.

One in three Danish companies experiences fraud

Sound familiar? See how to strengthen your defences and catch suspicious changes in ownership and management in time.

See the fraud module

Related companies

Company hierarchy

SL Holding 2017 ApS50%

Vindahl Holding ApS50%

Pharma Workforce Denmark ApS (this company)

Board network connections

Board members of Pharma Workforce Denmark ApS also hold positions in 3 other companies.

Person	Role here	Other companies
Lasse Vindahl	Chief Executive Officer	2 companies
Steffen Stenbøg Jensen	Management	1 company

Frequently asked questions

What is the CVR number of Pharma Workforce Denmark ApS?

Pharma Workforce Denmark ApS is registered with CVR / Virk under CVR 45480704.

What is the gross profit of Pharma Workforce Denmark ApS?

Pharma Workforce Denmark ApS reported a gross profit of DKK 481.7k in 2026.

Who is the CEO of Pharma Workforce Denmark ApS?

Lasse Vindahl is the CEO of Pharma Workforce Denmark ApS, in role since 2026.

Where is Pharma Workforce Denmark ApS headquartered?

Pharma Workforce Denmark ApS's registered address is Strøby Bygade 16.